Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

IMMUNOTHERAPY

Programmable bacteria as cancer therapy

Quorum-sensing bacteria can deliver a nanobody targeting the ‘don’t eat me’ ligand CD47 to tumors that results in systemic anti-tumor immunity-induced regression in mice.

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Inducing systemic anti-tumor immunity with quorum-sensing bacteria carrying nanobodies.

References

  1. 1.

    Starnes, C. O. Nature 357, 11–12 (1992).

    CAS  Article  Google Scholar 

  2. 2.

    Chowdhury, S. et al. Nat. Med. https://doi.org/10.1038/s41591-019-0498-z (2019).

  3. 3.

    Ingram, J. R., Schmidt, F. I. & Ploegh, H. L. Annu. Rev. Immunol. 36, 695–715 (2018).

    CAS  Article  Google Scholar 

  4. 4.

    Sockolosky, J. T. et al. Proc. Natl Acad. Sci. USA 113, E2646–E2654 (2016).

    CAS  Article  Google Scholar 

  5. 5.

    Jaiswal, S. et al. Cell 138, 271–285 (2009).

    CAS  Article  Google Scholar 

  6. 6.

    Weiskopf, K. Eur. J. Cancer 76, 100–109 (2017).

    CAS  Article  Google Scholar 

  7. 7.

    Weiskopf, K. et al. Science 341, 88–91 (2013).

    CAS  Article  Google Scholar 

  8. 8.

    Advani, R. et al. N. Engl. J. Med. 379, 1711–1721 (2018).

    CAS  Article  Google Scholar 

  9. 9.

    Ingram, J. R. et al. Proc. Natl Acad. Sci. USA 114, 10184–10189 (2017).

    CAS  Article  Google Scholar 

  10. 10.

    Liu, X. et al. Nat. Med. 21, 1209–1215 (2015).

    CAS  Article  Google Scholar 

  11. 11.

    Xu, M. M. et al. Immunity 47, 363–373.e365 (2017).

    CAS  Article  Google Scholar 

  12. 12.

    Silva, D. A. et al. Nature 565, 186–191 (2019).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Stephanie K. Dougan.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dougan, M., Dougan, S.K. Programmable bacteria as cancer therapy. Nat Med 25, 1030–1031 (2019). https://doi.org/10.1038/s41591-019-0513-4

Download citation

Further reading

Search

Quick links